Related Experiment Video
Updated: May 5, 2026

05:26
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
9.3K
Drug-eluting balloon to treat immediate post-coronary artery bypass grafting ST-elevation myocardial infarction: a
Muhammad Usman Shah1,2, Muhammad Anis Haider2, Krishna Poudyal2
1Joseph Banks Laboratories, University of Lincoln, Beevor St, Lincoln LN6 7DL, UK.
European Heart Journal. Case Reports
|June 3, 2024
Summary
Early ST-elevation myocardial infarction (STEMI) after coronary artery bypass graft (CABG) surgery requires prompt recognition. Drug-eluting balloons offer a potentially safer treatment option than drug-eluting stents for graft failure complications.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Surgery
Background:
- Coronary artery bypass graft (CABG) surgery is a major cardiovascular procedure.
- Post-operative ST-elevation myocardial infarction (STEMI) can occur due to graft failure.
- Percutaneous treatment of failing grafts with drug-eluting stents poses unique challenges.
Observation:
- A patient undergoing CABG developed persistent ST elevations post-operatively.
- Transthoracic echocardiography was inconclusive.
- Emergent angiography revealed thrombotic occlusion at the left internal mammary artery (LIMA) graft anastomosis.
Findings:
- Intervention via the LIMA graft was deemed high-risk.
- The occlusion was successfully treated by accessing native coronary arteries.
- A combination of semi-compliant and drug-eluting balloon angioplasty restored LIMA graft patency.
Implications:
- Early post-operative ST elevations may indicate new-onset STEMI.
- Drug-eluting balloons present a feasible and potentially safer alternative to drug-eluting stents for managing graft failure.
- This approach may improve outcomes in post-CABG STEMI patients.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome I: Introduction
2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K

